Zilico clinical founder appointed Personal Chair

Thursday 18th April 2013

Professor Tidy, a Consultant Gynaecological Oncologist at the Royal Hallamshire Hospital Sheffield, co-founded Zilico Ltd with Professor Brian Brown, from the University of Sheffield’s Department of Cardiovascular Science, with his early development work on Electrical Impedance Spectroscopy (EIS).

Prof. Tidy helped develop the clinical application of Electrical Impedance Spectroscopy (EIS) into a product that can address the need for improved detection and diagnosis of cervical neoplasia.

Pro-Vice-Chancellor for the Faculty of Medicine, Dentistry and Health at the University of Sheffield, Professor Tony Weetman said: "This honorary chair reflects the important relationship between the Faculty of Medicine, Dentistry and Health and our partner Trusts. John is an outstanding exemplar of an NHS colleague working closely with the University to conduct ground- breaking research and this award is very well-deserved."

Professor John Tidy, the clinical founder of Zilico Ltd, has been appointed a Personal Chair from the University of Sheffield – one of the highest academic distinctions conferred by the University.To have a chair appointed, individuals must have an international reputation in their field and demonstrate academic leadership in their discipline both within the University and externally, where recognition often extends beyond academia, through advising or giving expert opinion.

Last year, Prof. Tidy was the recipient of the Best Scientific Paper Award for his oral abstract presentation, “Improved Colposcopic Performance using Electrical Impedance Spectroscopy (APX100) as an Adjunct" at the ASCCP Biennial Scientific Meeting 2012 in San Francisco.

Prof. Tidy said: “I am both delighted and honoured to have received my personal chair from theUniversity of Sheffield. Maintaining an active research interest as a NHS consultant is both rewarding and challenging. The development of EIS has provided the very rare opportunity of taking laboratory based science
to a commercially available device to improve the management of women with cervical neoplasia.”

Zilico’s ZedScan I, which is due to be launched later this year, offers quicker more accurate
detection of cervical dysplasia in real time, removing several weeks of waiting time for diagnosis.
The first application of ZedScan I, which is positioned within the referral population, will reduce the
number of biopsies taken and has the potential to facilitate the wider use of ‘see and treat’

Sameer Kothari, Chief Executive of Zilico Ltd, said: “The appointment of a Personal Chair from the
University of Sheffield is well-deserved recognition of Prof. Tidy’s outstanding and world-leading
body of work in the fields of Obstetrics and Gynaecology. This is also excellent and timely news for Zilico, as we move closer to launching ZedScan I – a ï¿¼highly innovative technology borne out of Professors Tidy and Browns’ vision of the potential for EIS to improve detection and diagnosis of neoplasia.”